Merck KGaA

Introduction
Merck KGaA is a German multinational science and technology company founded in 1668, making it one of the world’s oldest pharmaceutical and chemical companies. It operates across healthcare, life science, and electronics, with a strong presence in pharmaceuticals, biotechnology, laboratory solutions, and materials for semiconductors. Outside the United States and Canada, it is known simply as Merck, while in those markets it operates as EMD Serono (healthcare) and MilliporeSigma (life sciences).

Mission and Vision

Mission: To make a positive difference to millions of lives every day by advancing science and technology in healthcare, life science, and electronics.
Vision: To be the most respected, science-driven technology company delivering sustainable innovation worldwide.

Products and Services

Healthcare: Prescription medicines for oncology, neurology, fertility, and endocrinology (e.g., Erbitux, Rebif, Mavenclad).
Life Sciences: Tools, reagents, and technologies through MilliporeSigma, serving biotech and pharmaceutical research.
Electronics (Performance Materials): Advanced materials and solutions for semiconductors, displays, and specialty chemicals.
Biotech & Innovation: Expanding into immuno-oncology, immunology, and next-generation technologies.

Growth and Innovation
Merck KGaA has diversified far beyond traditional pharmaceuticals, becoming a leader in life sciences and electronics materials. The acquisition of Sigma-Aldrich in 2015 bolstered its life sciences division. The company continues to innovate in biologics, gene therapy, and immuno-oncology, while also investing heavily in semiconductor materials and nanotechnology to support digital transformation.

Global Impact
With operations in over 70 countries, Merck KGaA plays a dual role in advancing healthcare and enabling technological innovation. Its MilliporeSigma unit is a global leader in scientific tools, critical for drug discovery and vaccine development. In healthcare, Merck KGaA therapies improve lives in oncology, neurology, and fertility. The company also prioritizes sustainability, aiming for climate neutrality by 2040.